Literature DB >> 2121988

The clinical features of osteogenesis imperfecta resulting from a non-functional carboxy terminal pro alpha 1(I) propeptide of type I procollagen and a severe deficiency of normal type I collagen in tissues.

W G Cole1, P E Campbell, J G Rogers, J F Bateman.   

Abstract

The features of a baby with lethal perinatal osteogenesis imperfecta (OI II), owing to a frameshift mutation that resulted in the production of a truncated and functionless carboxy terminal propeptide of the pro alpha 1(I) chain of type I procollagen, were studied. The baby (OI26) was heterozygous for an insertion of a single uridine nucleotide after base pair 4088 of the prepro alpha 1(I) mRNA of type I procollagen. Only normal type I collagen was incorporated into the extracellular matrix of bone and dermis resulting in a type I collagen content of about 20% of control tissues. The baby was born at 35 weeks' gestation and died shortly afterwards. He was small and had the radiographical features most like those of OI IIB. The skeleton was poorly ossified. The ribs were discontinuously beaded and the femora were broad with multiple healed fractures of the diaphyses and metaphyses. Other long bones had broad metaphyses with overmodelled diaphyses. The calvarium contained many hundreds of wormian bones. Histological examination showed grossly deficient endochondral and intramembranous ossification. The bone was of a woven type without evidence of lamellar bone or Haversian systems and the osteoblasts did not mature into osteocytes. The cortex of the femur contained Haversian canals but they were surrounded by loose collagen fibres and a mosaic pattern of woven bone and islands of cartilage. We propose that OI IIB can be sub-classified into two groups, one with helical mutations and both normal and mutant type I collagen in the tissues, and the other with carboxy terminal propeptide mutations and a severe type I collagen deficiency, but without mutant collagen in the tissues.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2121988      PMCID: PMC1017215          DOI: 10.1136/jmg.27.9.545

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  19 in total

1.  Lethal perinatal osteogenesis imperfecta due to the substitution of arginine for glycine at residue 391 of the alpha 1(I) chain of type I collagen.

Authors:  J F Bateman; D Chan; I D Walker; J G Rogers; W G Cole
Journal:  J Biol Chem       Date:  1987-05-25       Impact factor: 5.157

2.  Perinatal lethal osteogenesis imperfecta (OI type II): a biochemically heterogeneous disorder usually due to new mutations in the genes for type I collagen.

Authors:  P H Byers; P Tsipouras; J F Bonadio; B J Starman; R C Schwartz
Journal:  Am J Hum Genet       Date:  1988-02       Impact factor: 11.025

3.  Lethal osteogenesis imperfecta resulting from a single nucleotide change in one human pro alpha 1(I) collagen allele.

Authors:  D H Cohn; P H Byers; B Steinmann; R E Gelinas
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

4.  The clinical features of three babies with osteogenesis imperfecta resulting from the substitution of glycine by arginine in the pro alpha 1(I) chain of type I procollagen.

Authors:  W G Cole; C W Chow; J G Rogers; J F Bateman
Journal:  J Med Genet       Date:  1990-04       Impact factor: 6.318

5.  Substitution of arginine for glycine 664 in the collagen alpha 1(I) chain in lethal perinatal osteogenesis imperfecta. Demonstration of the peptide defect by in vitro expression of the mutant cDNA.

Authors:  J F Bateman; S R Lamande; H H Dahl; D Chan; W G Cole
Journal:  J Biol Chem       Date:  1988-08-25       Impact factor: 5.157

6.  A lethal variant of osteogenesis imperfecta has a single base mutation that substitutes cysteine for glycine 904 of the alpha 1(I) chain of type I procollagen. The asymptomatic mother has an unidentified mutation producing an overmodified and unstable type I procollagen.

Authors:  C D Constantinou; K B Nielsen; D J Prockop
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

7.  A frameshift mutation results in a truncated nonfunctional carboxyl-terminal pro alpha 1(I) propeptide of type I collagen in osteogenesis imperfecta.

Authors:  J F Bateman; S R Lamande; H H Dahl; D Chan; T Mascara; W G Cole
Journal:  J Biol Chem       Date:  1989-07-05       Impact factor: 5.157

8.  Recurrence risks and prognosis in severe sporadic osteogenesis imperfecta.

Authors:  E M Thompson; I D Young; C M Hall; M E Pembrey
Journal:  J Med Genet       Date:  1987-07       Impact factor: 6.318

9.  Introduction of the human pro alpha 1(I) collagen gene into pro alpha 1(I)-deficient Mov-13 mouse cells leads to formation of functional mouse-human hybrid type I collagen.

Authors:  A Schnieke; M Dziadek; J Bateman; T Mascara; K Harbers; R Gelinas; R Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

10.  Type III collagen can be present on banded collagen fibrils regardless of fibril diameter.

Authors:  D R Keene; L Y Sakai; H P Bächinger; R E Burgeson
Journal:  J Cell Biol       Date:  1987-11       Impact factor: 10.539

View more
  5 in total

1.  The phenotypic features of osteogenesis imperfecta resulting from a mutation of the carboxyl-terminal pro alpha 1 (I) propeptide that impairs the assembly of type I procollagen and formation of the extracellular matrix.

Authors:  W G Cole; C W Chow; J F Bateman; D O Sillence
Journal:  J Med Genet       Date:  1996-11       Impact factor: 6.318

Review 2.  New perspectives on osteogenesis imperfecta.

Authors:  Antonella Forlino; Wayne A Cabral; Aileen M Barnes; Joan C Marini
Journal:  Nat Rev Endocrinol       Date:  2011-06-14       Impact factor: 43.330

3.  Connective tissue disease: closing on the threshold.

Authors:  A Robinson
Journal:  CMAJ       Date:  1993-10-01       Impact factor: 8.262

4.  The clinicopathological features of three babies with osteogenesis imperfecta resulting from the substitution of glycine by valine in the pro alpha 1 (I) chain of type I procollagen.

Authors:  W G Cole; E Patterson; J Bonadio; P E Campbell; D W Fortune
Journal:  J Med Genet       Date:  1992-02       Impact factor: 6.318

Review 5.  Perinatal lethal osteogenesis imperfecta.

Authors:  W G Cole; R Dalgleish
Journal:  J Med Genet       Date:  1995-04       Impact factor: 6.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.